Our results provide a novel mechanism to account for our previous descriptions of the neuroprotective effects of proinsulin on retinal dystrophy [23–25] and cognitive impairment [27], and further support the validity of proinsulin-mediated stimulation of INSR as a candidate therapy for neurodegenerative conditions of the CNS. This evidence concerns the gene INS and Retinal dystrophy.